 The results of this study suggest that the bespectral index, BIS, can be used to accurately measure the level of sedation induced by dexmodetamidine. This finding suggests that the BIS may be a reliable tool for monitoring sedative levels in patients receiving dexmodetamidine. This article was authored by Sunghee Ki, Dongyeon Lee, Wonjin Lee, and others.